Post-transplant Relapse
Showing 1 - 25 of >10,000
Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Acute Myelogenous Leukemia (AML)
- low dose 5'-azacitidine
-
Basking Ridge, New Jersey
- +6 more
Dec 1, 2022
Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,
Completed
- Acute Myeloid Leukemia
- +2 more
- Decitabine
- +2 more
-
Minneapolis, Minnesota
- +2 more
Nov 2, 2022
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Atlanta, Houston (K-NK002, Conditioning Regimen, HaploBMT)
Withdrawn
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndromes (MDS)
- K-NK002
- +2 more
-
Atlanta, Georgia
- +1 more
Jun 16, 2021
hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
Recruiting
- Hepatocellular Carcinoma Recurrent
- Liver Transplant; Complications
- liver transplant
- +2 more
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 21, 2021
Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Stem Cell Transplantation
-
Tel Aviv, Israel
- +2 more
Jan 23, 2023
Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)
Completed
- Adult Acute Myeloid Leukemia in Remission
- Recurrent Adult Acute Myeloid Leukemia
-
Aurora, Colorado
- +1 more
Dec 30, 2021
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)
Recruiting
- Leukemia, Myeloid, Acute
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Mar 6, 2022
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
AML Patients After Stem Cell Transplant to Understand Relapse
Recruiting
- Acute Myeloid Leukemia in Remission
- Prospective determination of the clinical utility of measurable residual disease (MRD) testing
-
Duarte, California
- +3 more
Dec 7, 2022
Orthodontic Relapse Trial in Alexandria (Local Vitamin C injection, Oral Vitamin C supplement)
Recruiting
- Orthodontic Relapse
- Local Vitamin C injection
- Oral Vitamin C supplement
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Nov 17, 2023
Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cell Transplantation
- CARTemis-1
-
Santander, Cantabria, Spain
- +4 more
Aug 1, 2023
Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)
Withdrawn
- Leukemia
- Donor Enriched Activated Natural Killer Cell Infusion
- (no location specified)
Dec 20, 2022
Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)
Not yet recruiting
- Hematologic Malignancies
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 5, 2023
Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)
Recruiting
- Transplant-Related Hematologic Malignancy
- Sargramostim
- Control Arm
-
Atlanta, GeorgiaNorthside Hospital
Oct 19, 2022
MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)
Recruiting
- Myelodysplastic Syndromes
- DEC-C
- MyeloSeq-HD
-
Saint Louis, MissouriWashington University School of Medicine
Jan 18, 2023
CD19+ Malignancies: Relapse Post-allogeneic Transplant Trial in London (Infusion of modified CAR19 T-cells (4G7-CARD T-cells))
Active, not recruiting
- CD19+ Malignancies: Relapse Post-allogeneic Transplant
- Infusion of modified CAR19 T-cells (4G7-CARD T-cells)
-
London, United KingdomUniversity College London Hospital
Jun 16, 2021
Myeloid Leukemia, MDS Trial (IFN-?)
Not yet recruiting
- Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Nov 15, 2023
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Expanding Scope of Post-transplant HLA-specific Antibody
Not yet recruiting
- Kidney Transplant
- +7 more
- cf-DNA
- +2 more
-
Liverpool, Merseyside, United KingdomLiverpool University Hospitals NHS Foundation Trust
Aug 29, 2023